Stocks of Aurora Cannabis Inc. (NASDAQ:ACB) traded higher last session on Wall Street, up 6.02% to $0.67.
According to the data, Aurora Cannabis Inc. (NASDAQ:ACB) has 3 analysts covering its stock. The consensus rating among analysts is ‘Hold’. ACB stock price is now 2.40% away from the 50-day moving average and -37.24% away from the 200-day moving average. The market capitalization of the company currently stands at $282.96M.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
A total of 3 analysts have issued a hold rating and 0 have given it a buy rating.
.
Insiders disposed of 24,206 shares of company stock worth roughly $16218.02 over the past 1 year. A total of 0.06% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in ACB stock. A new stake in Aurora Cannabis Inc. shares was purchased by ETF MANAGERS GROUP, LLC during the first quarter worth $5,575,000. VERITION FUND MANAGEMENT LLC invested $2,035,000 in shares of ACB during the first quarter. In the first quarter, AXS INVESTMENTS LLC acquired a new stake in Aurora Cannabis Inc. valued at approximately $597,000. PINZ CAPITAL MANAGEMENT, LP acquired a new stake in ACB for approximately $399,000. GALLAGHER FIDUCIARY ADVISORS, LLC purchased a new stake in ACB valued at around $33,000 in the second quarter. In total, there are 277 active investors with 17.37% ownership of the company’s stock.
Friday’s opening bell rang with an opening price of $0.6300 for Aurora Cannabis Inc. (NASDAQ: ACB). During the past 12 months, Aurora Cannabis Inc. has had a low of $0.55 and a high of $3.10. As of last week, the company has a debt-to-equity ratio of 0.40, a current ratio of 4.10, and a quick ratio of 3.20. The fifty day moving average price for ACB is $0.6496 and a two-hundred day moving average price translates $1.0599 for the stock.
The latest earnings results from Aurora Cannabis Inc. (NASDAQ: ACB) was released for Dec, 2022. According to the Drug Manufacturers – Specialty & Generic Company, earnings per share came in at -$0.15, missing analysts’ expectations of -$0.06 by -0.09. This compares to -$0.30 EPS in the same period last year. The company reported revenue of $45.48 million for the quarter, compared to $48.08 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -5.42 percent. For the current quarter, analysts expect ACB to generate $48.23M in revenue.
Aurora Cannabis Inc.(ACB) Company Profile
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, Caribbeans, South America, and Israel; and distribution and sale of hemp-derived cannabidiol (CBD) products in the United States (U.S.) market. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, and cannabis extracts, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried milled strains and strain specific cannabis oils. Further, it offers patient counseling and outreach services. The company’s adult-use brand portfolio includes Aurora Drift, San Rafael ’71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
